CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities:
Net income (loss)	$ (12,974)	$ (1,063)
Adjustments to reconcile net loss to net cash used in operating activities:
(Income) Loss from discontinued operations, net of tax	0	400
Depreciation and amortization	4,075	3,890
Provision for expected credit losses	42	103
Impairment of capitalized software	341	384
Provision for excess and obsolete inventory	1,090	1,194
Share-based compensation expense	5,353	3,255
Amortization of debt discount (premium) and debt issuance costs, net	(238)	(65)
Deferred income taxes	6	6
Non-cash operating lease expense	435	527
Other	147	0
Changes in assets and liabilities:
Accounts receivable	(15,085)	(10,370)
Inventories	(2,287)	(2,664)
Prepaid expenses and other assets	(879)	1,355
Accounts payable	6,237	4,051
Accrued expenses and other liabilities	(7,853)	(7,404)
Operating lease liabilities	(472)	(654)
Operating cash flows from continuing operations	(22,062)	(7,055)
Operating cash flows from discontinued operations	0	(881)
Net cash used in operating activities	(22,062)	(7,936)
Cash flows from investing activities:
Purchases of property, plant and equipment	(479)	(220)
Additions to capitalized software development costs and purchases of intangible assets	(7,808)	(4,371)
Investing cash flows from continuing operations	(8,287)	(4,591)
Investing cash flows from discontinued operations	0	710
Net cash used in investing activities	(8,287)	(3,881)
Cash flows from financing activities:
Payments related to repayments of 2025 Convertible Notes	0	(14,949)
Draws on Working Capital Facility	10,000	0
Cash payments as part of preferred stock exchange	(3,334)	0
Proceeds from stock option exercises and employee stock purchase plan, net of taxes	699	272
Financing cash flows from continuing operations	7,365	(14,677)
Financing cash flows from discontinued operations	0	0
Net cash provided by (used in) financing activities	7,365	(14,677)
Effect of exchange rates on cash	(24)	119
Net decrease in cash and cash equivalents	(23,008)	(26,375)
Cash and cash equivalents, beginning of period	24,886	39,596
Cash and cash equivalents, end of period	1,878	13,221
Cash paid during the year for:
Interest	2,227	2,092
Income taxes	(12)	1,414
Supplemental disclosures of non-cash investing and financing activities:
Capital expenditures financed through accounts payable or accrued liabilities	674	225
Fair value of common stock, debt, and cash payables issued as part of preferred stock exchange	23,532	0
Carrying value of preferred stock removed as part of preferred stock exchange	$ 41,966	$ 0

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 1,878	$ 24,886
Accounts receivable, net of allowance for expected credit losses of $201 and $159, respectively	40,129	25,086
Inventories	8,923	7,726
Prepaid expenses and other current assets	7,168	6,389
Total current assets	58,098	64,087
Property, plant and equipment, net of accumulated depreciation of $12,445 and $26,063, respectively	1,318	1,087
Intangible assets, net of accumulated amortization of $34,839 and $32,336, respectively	23,350	20,676
Goodwill	3,949	3,949
Operating lease right-of-use assets	3,016	3,451
Other assets	657	557
Total assets	90,388	93,807
Current liabilities:
Accounts payable	28,687	23,583
Accrued expenses and other current liabilities	25,645	24,856
Total current liabilities	54,332	48,439
Long-term liabilities:
Operating lease liabilities	2,381	2,910
Deferred tax liabilities, net	192	186
Working Capital Facility	10,000	0
2029 Senior Secured Notes, net	50,291	41,611
Other long-term liabilities	3,754	4,705
Total liabilities	120,950	97,851
Commitments and contingencies (Note 9.)
Preferred stock, par value $0.001; 2,000,000 shares authorized:
Preferred stock, par value $0.001; 39,500 shares designated, no shares outstanding as of June 30, 2026, 25,000 issued and outstanding as of December 31, 2025 (aggregate liquidation preference of $41,966 as of December 31, 2025)	0	0
Common stock, par value $0.001; 150,000,000 shares authorized, 16,401,284 and 15,388,978 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively	16	15
Additional paid-in capital	875,237	903,899
Accumulated other comprehensive loss	420	403
Accumulated deficit	(906,235)	(908,361)
Total stockholders’ deficit	(30,562)	(4,044)
Total liabilities and stockholders’ deficit	$ 90,388	$ 93,807